The new strain of the virus (pictured) first arrived in England in November 2023 but has quickly spread, with the so-called ...

Musk's tweet comes against the backdrop of an executive order signed by US President Trump, prohibiting federal funding for ...

Efforts to arm farmers with tools and knowledge to battle bluetongue are ramping up across the country in an industry-wide ...

It’s a problem that’s been hovering since the 2017 Dengvaxia controversy led to the suspension of the Department of Health’s (DOH) vaccination campaign against this endemic scourge. On ...

New research led by scientists at La Jolla Institute for Immunology (LJI) reveals the workings of a human antibody called mAb ...

A new vaccine that boosts immunity against tuberculosis (TB) has been shown to be effective in pioneering pre-clinical trials ...

Vimkunya is supplied as an injectable suspension; the vaccine is administered intramuscularly as a single 0.8mL dose.

Immune cell populations of people with post-vaccination syndrome had lower levels of effector CD4 T cells and higher levels of CD8 T cells that secrete tumor necrosis factor (TNF) compared with ...

A new mRNA vaccine against tuberculosis (TB) is showing favorable results in preclinical trials. With only one currently ...

Yale researchers have examined post-vaccination syndrome (PVS), identifying persistent symptoms like fatigue and brain fog.

The world-wide pandemic involving SARS-CoV2 in which high infectivity and pathogenesis necessitated the critical need for rapid and accurate preclinical ...

Mucosal surfaces represent a primary interface between the human body and the environment, serving as critical portals for pathogens. Traditional vaccines ...